story of the week
Very High–Risk Primary Prostate Cancer Identified by p53 Immunohistochemistry
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
European Urology Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
p53 Immunohistochemistry to Identify Very High-risk Primary Prostate Cancer: A Prospective Cohort Study with Three Decades of Follow-up
Eur Urol Oncol 2021 Dec 27;[EPub Ahead of Print], KH Stopsack, DC Salles, JB Vaselkiv, ST Grob, LA Mucci, TL LotanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.